文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

预先存在的临床衰弱与脓毒症患者更差的临床结局相关

Preexisting Clinical Frailty Is Associated With Worse Clinical Outcomes in Patients With Sepsis.
PubMed 文献 · Crit Care Med · 2021-10-06
一句话结论脓毒症患者中,预先存在的临床衰弱(CFS 5-9分)与院内死亡率升高独立相关(校正OR 2.00),且存活出院后回家比例更低。

该研究为韩国19家三级或大学附属医院的前瞻性数据、全国性倾向评分匹配队列研究,纳入成人脓毒症患者,用临床衰弱量表(CFS)分为衰弱组(5-9分)与非衰弱组(1-4分),倾向评分匹配后各468例。主要终点院内死亡率在衰弱组为34.2%、非衰弱组为26.9%(p=0.019),校正OR 2.00(95%CI 1.39-2.89;p<0.001)。存活出院者中衰弱组回家比例64.0%,低于非衰弱组的81.3%(p<0.001)。提示对脓毒症患者应评估预先存在的衰弱以辅助预后判断与出院规划。

要点

  • 脓毒症患者入院时用临床衰弱量表(CFS)评估:5-9分为衰弱,1-4分为非衰弱,匹配队列平均年龄69±14岁。
  • 衰弱组院内死亡率34.2%,非衰弱组26.9%(p=0.019);校正混杂后OR 2.00(95%CI 1.39-2.89;p<0.001)。
  • 匹配队列中27.2%就诊时存在脓毒性休克,提示该关联覆盖含休克在内的脓毒症人群。
  • 存活出院者中,衰弱组回家比例64.0%,显著低于非衰弱组81.3%(p<0.001),影响出院去向规划。
  • 该研究为观察性关联,不能证明衰弱导致死亡,也不能推断干预衰弱可改善结局。

适用人群与场景

  • 韩国19家三级或大学附属医院收治的成人脓毒症患者(前瞻性收集数据,2019年9月至2020年2月)。
  • 倾向评分匹配队列468例衰弱(CFS 5-9分)与468例非衰弱(CFS 1-4分)患者,平均年龄69±14岁,27.2%就诊时合并脓毒性休克。

诊断标准与关键阈值

  • 衰弱评估采用临床衰弱量表(Clinical Frailty Scale):评分5-9分定义为衰弱,1-4分定义为非衰弱。
  • 脓毒症诊断依据原文为「诊断为脓毒症」的成人患者,未列出具体诊断标准界值。

处置流程与药物剂量

  • 原文未提及针对衰弱的具体治疗或药物处置方案;研究干预为None。
  • 原文提示对脓毒症患者应评估预先存在的临床衰弱状态,用于预后判断和出院去向规划。

红旗征与不能漏的情况

  • 原文未提及需要立刻处理或不能漏诊的具体红旗征及对应处理。

研究设计与关键结果

  • 研究类型:全国性倾向评分匹配队列研究,分析2019年9月至2020年2月前瞻性收集的数据,共19家中心。
  • 匹配后队列各468例(衰弱vs非衰弱),所有协变量失衡被消除,平均年龄69±14岁,27.2%就诊时有脓毒性休克。
  • 主要终点院内死亡率:衰弱组34.2% vs 非衰弱组26.9%(p=0.019);多因素logistic回归校正OR 2.00(95%CI 1.39-2.89;p<0.001)。
  • 关键次要终点:存活出院者中回家比例衰弱组64.0% vs 非衰弱组81.3%(p<0.001)。

证据类型、等级与局限

  • 证据类型:观察性队列研究(倾向评分匹配),非随机对照试验。
  • 局限:为观察性设计,仅能提示关联而非因果;原文未提及其他局限,但设计上为单国多家中心、非盲法、匹配后样本量有限。

对床旁实践的改变

  • 对成人脓毒症患者,可在入院时用临床衰弱量表(CFS)评估预先存在的衰弱(5-9分为衰弱),辅助识别院内死亡风险较高者并加强监护沟通。
  • 对衰弱的脓毒症存活者,出院规划应考虑其回家可能性较低(64.0% vs 81.3%),提前安排康复与出院支持。
  • 该研究为观察性关联,不能据此认为纠正衰弱可降低死亡率,也不支持将CFS评分作为治疗启动或停止的决策阈值。

指南或共识出处

  • 原文未提及指南或共识名称;来源为Crit Care Med发表的原创研究。

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVES: Frailty is a multidimensional syndrome or state of increased vulnerability to poor resolution of homoeostasis following a stressor event. Frailty is common in patients with sepsis. Sepsis and frailty are both associated with older age and chronic medical conditions. However, there is limited evidence about the direct association between frailty and sepsis. The aim of this study is to determine the association between preexisting clinical frailty and clinical outcomes in patients with sepsis.

DESIGN: A nationwide propensity score-matched cohort study analyzing data prospectively collected between September 2019 and February 2020.

SETTING: Nineteen tertiary or university-affiliated hospitals in South Korea.

PATIENTS: Adult patients who were diagnosed with sepsis.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Frailty status was assessed using the Clinical Frailty Scale. All patients were classified as "frail" (Clinical Frailty Scale score, 5-9) or "nonfrail" (Clinical Frailty Scale score, 1-4). Propensity score matching identified comparable nonfrail patients. The primary outcome was inhospital mortality. Multivariable logistic regression analysis was used to evaluate the association between frailty and inhospital mortality. The propensity score-matched cohort comprised 468 nonfrail patients and 468 frail patients; all covariate imbalances were alleviated. In the matched cohort (mean age, 69 ± 14 yr), 27.2% had septic shock at presentation. Inhospital mortality was 34.2% in the frail group and 26.9% in the nonfrail group (p = 0.019). The adjusted odds ratio for inhospital mortality in the frail group compared with the nonfrail group was 2.00 (95% CI, 1.39-2.89; p < 0.001). Among the patients who survived to discharge, the frail group was less likely to be discharged home compared with the nonfrail group, 64.0% versus 81.3%, respectively (p < 0.001).

CONCLUSIONS: In patients with sepsis, preexisting clinical frailty is associated with worse clinical outcomes than that in nonfrail patients, including inhospital mortality and discharge to home.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Lee HY, Lee J, Jung YS, et al. Preexisting Clinical Frailty Is Associated With Worse Clinical Outcomes in Patients With Sepsis. Crit Care Med. 2021. PMID: 34612849. doi:10.1097/CCM.0000000000005360

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。